Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul:108:1-3.
doi: 10.1016/j.ijid.2021.03.087. Epub 2021 Apr 3.

High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: A preliminary report

Affiliations

High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: A preliminary report

Jean-Christophe Lagier et al. Int J Infect Dis. 2021 Jul.

Abstract

Objectives: In a conventional hospital ward, we used high-flow nasal oxygen (HFNO) to treat elderly COVID-19 patients noneligible for intensive care unit transfer.

Methods: This study was conducted in the Institut Hospitalo-Universitaire Méditerranée Infection, Assistance Publique-Hôpitaux de Marseille (AP-HM), France. We used high-flow nasal oxygen (HFNO) in our conventional infectious disease ward from 15 September 2020 for elderly patients noneligible for intensive care unit transfer.

Results: Of the 44 patients (median age 83 years (57-94), mean: 80.25), 61.4% (27/44) were men. The median Charlson score was 7 (1-15). The median of the NEWS-2 score upon admission was 8 (3-11) and was 10 at the time of initiation of HFNO. The median PaO2/FiO2 ratio was 103 (71-151) prior to HNFO initiation. Among the 44 patients, 16 patients (36.4%) had been weaned from HFNO, and 28 patients had died (63.6%).

Conclusions: In this preliminary report, we observed that HFNO saved the lives of one-third of elderly COVID-19 patients who would have systematically died.

Keywords: COVID-19; Conventional hospital ward; Elderly patients; High-flow oxygen therapy; SARS-CoV2.

PubMed Disclaimer

References

    1. Brouqui P., Amrane S., Million M., Cortaredona S., Parola P., Lagier J.C. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int J Infect Dis. 2020;102(October):233–238. doi: 10.1016/j.ijid.2020.10.067. Online ahead of print. - DOI - PMC - PubMed
    1. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383. - PubMed
    1. Frieden T.R. Evidence of health decision making-beyond randomized controlled trials. N Engl J Med. 2017;377:465–475. - PubMed
    1. Guy T., Créac’hcadec A., Ricordel C., Salé A., Arnouat B., Bizec J.L. High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU. Eur Respir J. 2020;(September) doi: 10.1183/13993003.01154-2020. Online ahead of print. PMID: 32859678. Free PMC article. - DOI - PMC - PubMed
    1. Johns Hopkins University . 2021. Coronavirus resource center. COVID-19 dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins University (JHU) [Accessed at https://coronavirus.jhu.edu/map.html on 13 November 2020]